By analyzing clinical samples from melanoma patients with different grades of stemness, we noted that HDGF and LGR5 correlated with the expression of a commonly used CSC marker, CD133, which was co-localized in the microvascular regions of melanoma tissues. The gene discussed is HDGF; the disease is melanoma.